IL53440A0 - 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them - Google Patents

2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them

Info

Publication number
IL53440A0
IL53440A0 IL53440A IL5344077A IL53440A0 IL 53440 A0 IL53440 A0 IL 53440A0 IL 53440 A IL53440 A IL 53440A IL 5344077 A IL5344077 A IL 5344077A IL 53440 A0 IL53440 A0 IL 53440A0
Authority
IL
Israel
Prior art keywords
hydrazines
adamantyl
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL53440A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Priority to IL53440A priority Critical patent/IL53440A0/xx
Publication of IL53440A0 publication Critical patent/IL53440A0/xx
Priority to CA000315361A priority patent/CA1119170A/en
Priority to DE7878101412T priority patent/DE2862274D1/de
Priority to EP78101412A priority patent/EP0002066B1/en
Priority to ZA00786543A priority patent/ZA786543B/xx
Priority to JP14492778A priority patent/JPS5488249A/ja
Priority to AU41843/78A priority patent/AU4184378A/en
Priority to US05/963,113 priority patent/US4254128A/en
Priority to IT30071/78A priority patent/IT1101419B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/30—Nitrogen atoms non-acylated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL53440A 1977-11-22 1977-11-22 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them IL53440A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL53440A IL53440A0 (en) 1977-11-22 1977-11-22 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them
CA000315361A CA1119170A (en) 1977-11-22 1978-10-31 2-adamantyl hydrazines, their preparation and pharmaceutical compositions containing them
DE7878101412T DE2862274D1 (en) 1977-11-22 1978-11-20 2-adamantyl hydrazines and pharmaceutical compositions containing them
EP78101412A EP0002066B1 (en) 1977-11-22 1978-11-20 2-adamantyl hydrazines and pharmaceutical compositions containing them
ZA00786543A ZA786543B (en) 1977-11-22 1978-11-21 2-adamantyl hydrazines,their preparation and pharmaceutical compositions containing them
JP14492778A JPS5488249A (en) 1977-11-22 1978-11-21 22adamantylhydrazine derivatives or their acid added salts
AU41843/78A AU4184378A (en) 1977-11-22 1978-11-22 2-adamantyl hydrazines
US05/963,113 US4254128A (en) 1977-11-22 1978-11-22 2-Adamantyl hydrazines and biocidal compositions thereof
IT30071/78A IT1101419B (it) 1977-11-22 1978-11-22 2-adamantil idrazione e composizioni che le contengono

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL53440A IL53440A0 (en) 1977-11-22 1977-11-22 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
IL53440A0 true IL53440A0 (en) 1978-01-31

Family

ID=11049917

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53440A IL53440A0 (en) 1977-11-22 1977-11-22 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them

Country Status (9)

Country Link
US (1) US4254128A (xx)
EP (1) EP0002066B1 (xx)
JP (1) JPS5488249A (xx)
AU (1) AU4184378A (xx)
CA (1) CA1119170A (xx)
DE (1) DE2862274D1 (xx)
IL (1) IL53440A0 (xx)
IT (1) IT1101419B (xx)
ZA (1) ZA786543B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683311A (en) * 1986-01-22 1987-07-28 Pennwalt Corporation Spiro[isoxazalidine-3,2'-tricyclo[3.3.1.13,7 ] decanes]
US5488035A (en) * 1991-12-06 1996-01-30 Pioneer Hi-Bred International, Inc. Peptide with inhibitory activity towards plant pathogenic fungi
US5977360A (en) 1996-12-27 1999-11-02 Japan Hydrazine Co., Ltd. Process for producing cyclic hydrazine derivatives, tetra-hydropyridazine and hexahydropyridazine
WO1999026927A2 (en) * 1997-11-21 1999-06-03 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists for treating central nervous system diseases
US6429207B1 (en) 1997-11-21 2002-08-06 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
MX2010011678A (es) * 2008-04-22 2011-01-21 Univ Northeastern Metodos de tratamiento de infecciones micoticas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054275A (xx) * 1963-05-01
US3328251A (en) * 1965-12-30 1967-06-27 Du Pont Pharmaceutical compositions and methods utilizing 2-aminoadamantane and its derivatives
AT274779B (de) * 1966-09-09 1969-09-25 Bayer Ag Verfahren zur Herstellung von neuen 1-Hydrazinoadamantanen
US4100170A (en) * 1967-12-18 1978-07-11 Pennwalt Corporation Anorectic adamantane derivatives and method of using the same
US3703537A (en) * 1969-10-28 1972-11-21 Cilag Chemie Adamantyl urea derivatives
US3838151A (en) * 1972-08-11 1974-09-24 Richardson Merrell Inc Cycloalkyllactamimides
US4061774A (en) * 1974-03-02 1977-12-06 Lilly Industries, Limited Halogenated amino methyl adamantane derivatives

Also Published As

Publication number Publication date
AU4184378A (en) 1979-05-31
IT7830071A0 (it) 1978-11-22
US4254128A (en) 1981-03-03
EP0002066B1 (en) 1983-05-25
EP0002066A1 (en) 1979-05-30
DE2862274D1 (en) 1983-07-07
CA1119170A (en) 1982-03-02
ZA786543B (en) 1979-10-31
IT1101419B (it) 1985-09-28
JPS5488249A (en) 1979-07-13

Similar Documents

Publication Publication Date Title
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
IL51816A0 (en) Novel steroids their preparation and pharmaceutical compositions containing them
IL53043A0 (en) Novel 1-aryloxy-2-hydroxy-3-aminopropane - derivatives their preparation and pharmaceutical compositions containing them
IL53589A0 (en) Novel nucleosides their preparation and pharmaceutical compositions containing them
IL54519A0 (en) 2-diarylalkyl-1-azabicyclo (2,2,2) octanes, their preparation and pharmaceutical compositions containing them
IL53441A0 (en) Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them
GB1544191A (en) Acylaminopiperidines processes for their preparation and pharmaceutical compositions containing them
IL52137A0 (en) Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them
GB2002779B (en) Peptides their preparation and pharmaceutical compositions containing them
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
IL53440A0 (en) 2-adamantyl hydrazines their preparation and pharmaceutical compositions containing them
GB2001653B (en) Peptides their preparation and pharmaceutical compositions containing them
GB2018771B (en) 2-aminomethylphenols and their preparation and compositions containing them
GB2010816B (en) Carbothioamides compositions containing them their preparation and use
GB2011382B (en) Bis(nitrosoureido) polyol derivatives their preparation and pharmaceutical compositions containing them
GB2001980B (en) Dioxazocine derivatives their preparation and compositions containing them
GB2010261B (en) Phenoxyalkanolamine derivatives the preparation thereof and pharmaceutical compositions containing them
IL51468A0 (en) Novel d-homosteroids their preparation and pharmaceutical compositions containing them
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL54899A (en) Pyridazinylhydrazones,their preparation and pharmaceutical compositions containing them
IL52006A0 (en) Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them
IL52562A0 (en) Novel cyanoprostaglandins their preparation and pharmaceutical compositions containing them
IL54001A (en) 2,4-dichlorophenyl-imidazolyl-ethan-ones and-ols,their preparation and pharmaceutical compositions containing them
IL52853A0 (en) New aryl-alkylamines their preparation and pharmaceutical compositions containing them
IL56021A (en) 2-heterocyclylalklyl-6-methoxy-naphathalenes,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void